Loading
Life sciences · Journal article
Acs Applied Bio Materials · November 3, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Nonpermeating cryoprotective agents (CPAs) represent an alternative to reduce the dependence on small molecules such as dimethyl sulfoxide and glycerol that may cause toxic effects in sensitive cell lines. In this work, a library of lactone-modified poly(vitamin B5 analogous monomer (B5AMA))-based nanogels with systematically tuned amphipathicity and crosslinker chemistry were synthesized and evaluated as extracellular CPAs for the cryopreservation of human red blood cells and murine breast cancer cells. Three γ-hydroxy(amino)amide methacrylamide comonomers possessing variable alkyl chain lengths were prepared and incorporated into poly(B5AMA) nanogel networks utilizing three structurally distinct bifunctional crosslinkers. Nanogels were characterized by dynamic light scattering, zeta potential, and transmission electron microscopy, demonstrating sub-100 nm dimensions and a porous structure. The nanogel formulations prepared with different crosslinkers and comonomers possessed different volume phase transition temperatures and hence overall amphipathicity and demonstrated enhanced IRI activities relative to hydrophilic analogues. The nanogel synthesized with different crosslinkers clearly demonstrated the role of crosslinker amphipathicity in the cryopreservation efficacies of mammalian cells. Meanwhile, amphipathic formulations prepared by copolymerizing B5AMA with γ-hydroxy(amino)amide methacrylamide comonomers in the presence of a specific crosslinker demonstrated crosslinker- and comonomer-type-dependent cryopreservation efficacies in different cell types. Collectively, these findings demonstrate that amphipathicity, crosslinker chemistry, polymer network architecture, and macromolecular crowding jointly govern cryoprotective outcomes, positioning lactone-modified poly(B5AMA) nanogels as promising macromolecular CPAs for use in the preservation of cell-based therapies.